francia 6

NYSE Euronext Announces Trading Volumes for December 2013

  • Home
  • ETF Europe
  • NYSE Euronext Announces Trading Volumes for December 2013

Global Derivatives ADV Down Year-over-Year and Month-over-Month, excluding Bclear
European Cash Equities ADV Up Year-over-Year but Down Sequentially
U.S. Cash ADV Down Year-over-Year but Up Sequentially…..


    Sign up for our weekly Newsletter and receive the latest ETF and ETC news.

    Click here to register for your free copy


    NYSE Euronext today announced trading volumes for its global derivatives and cash equities exchanges for December 20131.   Global derivatives average daily volume (“ADV”) of 5.9 million contracts, excluding Bclear in December 2013 decreased 7.6% compared to December 2012 and decreased 10.8% from November 2013.  U.S. equity options volumes in December 2013 decreased 13.2% compared to December 2012 and decreased 9.9% sequentially.   ADV in U.S. cash equities declined 8.7% year-over-year but increased 0.9% month-over-month. European cash equities ADV in December 2013 increased 13.6% compared to December 2012, but decreased 9.3% from November 2013 levels.

    Highlights

    NYSE Euronext global derivatives ADV in December 2013 of 5.9 million contracts, excluding Bclear decreased 7.6% from December 2012 and decreased 10.8% from November 2013 levels. 

    NYSE Euronext European derivatives products ADV in December 2013 of 2.4 million contracts, excluding Bclear, increased 1.5% compared to December 2012 but decreased 13.3% from November 2013 levels.   Including Bclear, NYSE Liffe’s trade administration and clearing service for OTC products, European derivatives ADV decreased 11.3% compared to December 2012, and decreased 3.9% from November 2013. Total MSCI World Index yearly volumes were up 31% to 337,000 lots, with open interest of over 110,000 lots, up 245% from December 2012.

    NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options) ADV of 3.4 million contracts in December 2013 decreased 13.2% compared to December 2012 levels and decreased 9.9% from November 2013 levels.  NYSE Euronext’s U.S. options exchanges accounted for 24.5% of total U.S. consolidated equity options trading in December 2013, down from 27.2% in December 2012, and down from 26.0% in November 2013.

    NYSE Liffe U.S. ADV of approximately 65,300 contracts decreased from 72,600 contracts in December 2012 but increased from 32,300 contracts in November 2013.  2013 ADV vs. 2012 ADV for MSCI futures is up 71%.  OI for year end 2013 vs. year end 2012 is up 48%. 

    NYSE Euronext European cash products ADV of 1.2 million transactions in December      2013 increased 13.6% compared to December 2012, but decreased 9.3% compared to November 2013. 

    NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE MKT) handled ADV of 1.4 billion shares in December 2013 decreased 8.7% compared to December    2012 but increased 0.9% compared to November 2013.  NYSE Euronext’s Tape A matched market share in December 2013 was 31.0%, down from 31.9% in December    2012, but up from 29.5% in November 2013. 

    The preliminary average net revenue per transaction type (as defined below) for each of the primary trading venues in the fourth quarter of 2013 is included below:

    Trading Venue

    Q4 2013

    Q3 2013

    Q4 2012

    European Derivatives (ex Bclear)1

    $0.664

    $0.622

    $0.673

    U.S. Options2

    $0.170

    $0.165

    $0.144

    U.S. Cash3

    $0.049

    $0.049

    $0.040

    EU Cash4

    $0.610

    $0.543

    $0.583

    1 Average net revenue per contract, excluding Bclear.  
    2 Average net revenue per contract.
    3 Average net revenue per 100 shares handled. 
    4 Average net revenue per transaction.

    Source: ETFWorld.co.uk


    Subscribe to Our Newsletter
    I have read the Privacy policyand I authorize the processing of my personal data for the purposes indicated therein.

    Newsletter ETFWorld.nl

    I have read the Privacy policyand I authorize the processing of my personal data for the purposes indicated therein.